Heltshe, Sonya L <br/><br/>
Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.  [electronic resource] 

 -  Contemporary clinical trials  01 2018 
 - 35-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-2030 
<br/><br/><label>Standard No.: </label>10.1016/j.cct.2017.11.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Anti-Bacterial Agents--administration & dosage<br/>Cystic Fibrosis--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Research Design<br/>Respiratory Function Tests<br/>Time Factors